Pharmaceutical, Drugs, Medicine, Biology, FDA.
developers may be unfamiliar with these processes, which can lead to delays and setbacks. Pre-IND meetings with regulatory agencies can help to clarify the requirements for drug development and ensure that studies are designed to meet these requirements. This high failure rate highlights the